产品研发
RESEARCH

Novel Affinity Ligands- nanoselect

    Nanobody and Affibody are new novel affinity ligands, NBbiolab development a series of  unique affinity purification solution based on Camelid&shark-derived single domain antibody fragments(~15KD) and Affibody(6.5KD). These small affinity ligands, are the platform solution for any biopharmaceutical purification challenge and have been proven for many applications to result in a higher yield and an increased purity of the biopharmaceutical, as well as a reduction in the number of purification steps which all affect the cost of goods of the biopharmaceutical. In addition, nanoselect  ligands can be tailored to protect the biopharmaceutical by mild elution conditions. The manufacturing in yeast and Ecoli, without animal derived components, results in a high quality product without toxins and viruses.




Copyright ©2017 成都阿帕克生物科技有限公司 蜀ICP备17007098号-1    
地址:成都高新区孵化园1号B座B3-23 电话:400-166-9953 13551086942 邮箱:service@nb-biolab.com
24小时服务热线
400-166-9953